Paladin Labs: Isofol Medical : announces licensing agreement for Paladin Labs Inc. to commercialize arfolitixorin in Canada

(marketscreener.com) GOTHENBURG, Sweden, Nov. 2, 2020 /PRNewswire/ -- Isofol Medical AB , is pleased to announce today a definitive license agreement with Endo Ventures Limited, a subsidiary of Endo International plc plc, for the registration and commercialization of arfolitixorin on an exclusive basis in Canada. With the consent of Isofol, Endo Ventures...https://www.marketscreener.com/quote/stock/ISOFOL-MEDICAL-AB-PUBL-110658361/news/Isofol-Medical-announces-licensing-agreement-for-Paladin-Labs-Inc-to-commercialize-arfolitixorin-31671631/?utm_medium=RSS&utm_content=20201102